VarmX
ID: 5868342VarmX is a Netherlands-based biotechnology company manufacturing therapeutic proteins to restore blood clotting in bleeding patients.
7
Funding Rounds
$93.8m
Money raised
Recent Funding Rounds
Overview
VarmX is a Netherlands-based biotechnology company manufacturing therapeutic proteins to restore blood clotting in bleeding patients.
- Website:
- Business model: B2B
- Headquarters: The Hague
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** Bi**** |
|
- | - |
| Pi**** Re***** |
|
- | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** Bi**** |
|
- | - |
Funding
Funding series
Funding Series Analysis
The company VarmX has raised a total of $45.7m in funding over 7 rounds.
Key Insights:
- VarmX May 2023 Series B Funding Round: $37m
- VarmX Series A round, July 2018: $8.7m
- VarmX Series A Funding Round July 2018: $8.85m
- VarmX Seed Funding Round December 2016: $333k
- VarmX Seed Funding Round June 2017: $1.13m
- VarmX Series B Funding Round July 2020: $37.76m
Industries
VarmX is active in the following industries: